Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease that causes obstructed airflow within the lungs, resulting in shortness of breath with everyday activities. Chronic bronchitis and emphysema are the two most common conditions contributing to COPD. People suffering from lung cancer and heart disease may also develop the symptoms of COPD and may benefit from supplemental oxygen.
Not everyone with COPD requires oxygen therapy, but for many patients it is an essential part of their treatment plan. COPD patients may be prescribed oxygen therapy if the physician concludes that supplemental oxygen may address hypoxia -- if the level of oxygen in their bloodstream is below normal -- or improve their health and well-being. Hypoxia is often determined by an arterial blood gas test, or by a pulse oximeter.
By increasing the amount of oxygen in the patient’s body, oxygen therapy often improves quality of life for people with COPD by decreasing their shortness of breath, fatigue, and potentially improving mental alertness, mood and quality of sleep.
The choice of oxygen delivery devices depends on the patient’s oxygen requirement, efficacy of the device, reliability, ease of therapeutic application and patient acceptance. Although the oxygen device design plays an important role in selection of these devices, clinical assessment and performance ultimately determine how and which device should be selected.
Currently in common use, a two-pronged nasal cannula is an oxygen medical device that delivers oxygen from an oxygen source to two small plastic tubes placed in the nostrils. Oxygen can be administered in a home setting, hospital, treatment center, and when the patient is mobile.
In this paper, we examine issues related to the method of delivery of oxygen in supplemental oxygen therapy and explore the advantages of a breakthrough redesign of the nasal cannula delivery system -- a single-prong nasal cannula -- for people living with COPD.
With the vast number of COPD patients struggling to breathe and requiring low flow supplemental oxygen, the introduction of the discreet, lightweight Uni-flo2 Single-nasal Cannula System (Uni-flo2) is a welcome life-changing experience that may optimize oxygen metabolism and improve health.
Click here to download the full white paper: Breathe Easier: Single-Prong Cannula Represents Important Breakthrough in Oxygen Therapy for COPD Patients